CARsgen Therapeutics Holdings Limited (HKG:2171)
10.87
-1.09 (-9.11%)
At close: Mar 6, 2026
HKG:2171 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,123 | 1,479 | 1,850 | 2,268 | 691.28 |
Short-Term Investments | - | 0.84 | 1.13 | 6.31 | 2,321 |
Cash & Short-Term Investments | 1,123 | 1,480 | 1,851 | 2,274 | 3,012 |
Cash Growth | -24.09% | -20.04% | -18.62% | -24.50% | 188.31% |
Accounts Receivable | 15.55 | 18.29 | - | - | - |
Other Receivables | 16.04 | 14.52 | 11.82 | 16.58 | 49.05 |
Receivables | 31.6 | 32.8 | 11.82 | 16.58 | 49.05 |
Inventory | 7.14 | 6.93 | 0.68 | - | - |
Other Current Assets | 15.94 | 10.65 | 9.71 | 9.72 | 9.57 |
Total Current Assets | 1,178 | 1,530 | 1,873 | 2,301 | 3,071 |
Property, Plant & Equipment | 97.85 | 123.95 | 361.39 | 441.38 | 386.19 |
Other Intangible Assets | 1.15 | 2.94 | 8.66 | 14.48 | 20.13 |
Other Long-Term Assets | 15.06 | 15.87 | 14.08 | 6.32 | 28.46 |
Total Assets | 1,292 | 1,673 | 2,257 | 2,763 | 3,506 |
Accrued Expenses | 138.47 | 171.37 | 151.04 | 137.2 | 94.71 |
Current Portion of Long-Term Debt | - | 20.29 | 2.52 | 4.85 | 219.33 |
Current Portion of Leases | 12.84 | 13.44 | 12.23 | 17.13 | 14.03 |
Current Income Taxes Payable | - | - | - | 1.34 | 7.65 |
Current Unearned Revenue | 54.15 | 38.66 | 23.46 | 6.57 | 10.14 |
Other Current Liabilities | - | 10.25 | 6.97 | 3.92 | 43.32 |
Total Current Liabilities | 205.46 | 254.01 | 196.22 | 171 | 389.17 |
Long-Term Debt | - | 68.85 | - | 2.52 | 7.38 |
Long-Term Leases | 48.34 | 63.84 | 70.47 | 94.94 | 97.31 |
Long-Term Unearned Revenue | 184.91 | 229.63 | 188.83 | 21.18 | 15.12 |
Other Long-Term Liabilities | 74.09 | - | - | - | - |
Total Liabilities | 512.8 | 616.33 | 455.51 | 289.65 | 508.98 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | - | 9,388 | 9,437 | 9,430 | 9,420 |
Retained Earnings | - | -8,988 | -8,190 | -7,442 | -6,550 |
Comprehensive Income & Other | 783.32 | 656.5 | 554.6 | 484.89 | 126.63 |
Total Common Equity | 783.32 | 1,057 | 1,802 | 2,473 | 2,997 |
Minority Interest | -3.98 | - | - | - | - |
Shareholders' Equity | 779.34 | 1,057 | 1,802 | 2,473 | 2,997 |
Total Liabilities & Equity | 1,292 | 1,673 | 2,257 | 2,763 | 3,506 |
Total Debt | 61.18 | 166.42 | 85.22 | 119.45 | 338.05 |
Net Cash (Debt) | 1,062 | 1,313 | 1,766 | 2,155 | 2,674 |
Net Cash Growth | -19.13% | -25.61% | -18.06% | -19.42% | 183.13% |
Net Cash Per Share | 1.95 | 2.38 | 3.17 | 3.91 | 6.91 |
Filing Date Shares Outstanding | 535.95 | 549.41 | 575.64 | 572.63 | 567.54 |
Total Common Shares Outstanding | 535.95 | 549.41 | 575.64 | 572.63 | 567.54 |
Working Capital | 972.63 | 1,276 | 1,677 | 2,130 | 2,682 |
Book Value Per Share | 1.46 | 1.92 | 3.13 | 4.32 | 5.28 |
Tangible Book Value | 782.17 | 1,054 | 1,793 | 2,459 | 2,977 |
Tangible Book Value Per Share | 1.46 | 1.92 | 3.11 | 4.29 | 5.24 |
Buildings | - | 81.9 | 81.32 | 80.92 | 36.82 |
Machinery | - | 216.87 | 217.89 | 201.82 | 176.69 |
Construction In Progress | - | 12.68 | 2.13 | 12.15 | 152.14 |
Leasehold Improvements | - | 199.2 | 200.93 | 197.47 | 11.79 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.